# MGP Ingredients Inc: financial statements, quarterly

MGPI · Nasdaq · CIK 835011 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mgpi.md) · [Financials](/companies/mgpi/financials.md) · [Filings](/companies/mgpi/filings.md) · [Insiders](/companies/mgpi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mgpi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [209](/filings/0001628280-24-033884.md) | [212](/filings/0001628280-24-044424.md) | [215 d](/filings/0000835011-26-000031.md) | [171](/filings/0001628280-25-021329.md) | [191](/filings/0001628280-25-036842.md) | [161](/filings/0000835011-25-000097.md) | [181 d](/filings/0000835011-26-000031.md) | [122](/filings/0000835011-26-000068.md) | [145](/filings/0001628280-25-036842.md) | [131](/filings/0000835011-25-000097.md) | [138 d](/filings/0000835011-26-000031.md) | [106](/filings/0000835011-26-000068.md) |
| Cost of revenue | $m | [133](/filings/0001628280-24-033884.md) | [138](/filings/0001628280-24-044424.md) | [130 d](/filings/0000835011-26-000031.md) | [108](/filings/0001628280-25-021329.md) | [108](/filings/0001628280-25-036842.md) | [95.6](/filings/0000835011-25-000097.md) | [106 d](/filings/0000835011-26-000031.md) | [78.3](/filings/0000835011-26-000068.md) | [87.1](/filings/0001628280-25-036842.md) | [81.5](/filings/0000835011-25-000097.md) | [90.1 d](/filings/0000835011-26-000031.md) | [72.8](/filings/0000835011-26-000068.md) |
| Gross profit | $m | [76.3](/filings/0001628280-24-033884.md) | [73.4](/filings/0001628280-24-044424.md) | [85.1 d](/filings/0000835011-26-000031.md) | [62.8](/filings/0001628280-25-021329.md) | [83.2](/filings/0001628280-25-036842.md) | [65.8](/filings/0000835011-25-000097.md) | [74.5 d](/filings/0000835011-26-000031.md) | [43.3](/filings/0000835011-26-000068.md) | [58.4](/filings/0001628280-25-036842.md) | [49.4](/filings/0000835011-25-000097.md) | [48.3 d](/filings/0000835011-26-000031.md) | [33.6](/filings/0000835011-26-000068.md) |
| Selling, general and administrative | $m | [23.5](/filings/0001628280-24-033884.md) | [21.6](/filings/0001628280-24-044424.md) | [25.8 d](/filings/0000835011-26-000031.md) | [21.0](/filings/0001628280-25-021329.md) | [22.8](/filings/0001628280-25-036842.md) | [17.2](/filings/0000835011-25-000097.md) | [20.4 d](/filings/0000835011-26-000031.md) | [21.2](/filings/0000835011-26-000068.md) | [23.2](/filings/0001628280-25-036842.md) | [18.9](/filings/0000835011-25-000097.md) | [21.5 d](/filings/0000835011-26-000031.md) | [21.1](/filings/0000835011-26-000068.md) |
| Operating income | $m | [44.1](/filings/0001628280-24-033884.md) | [19.8](/filings/0001628280-24-044424.md) | [43.1 d](/filings/0000835011-26-000031.md) | [28.9](/filings/0001628280-25-021329.md) | [43.4](/filings/0001628280-25-036842.md) | [32.6](/filings/0000835011-25-000097.md) | [(30.4) d](/filings/0000835011-26-000031.md) | [(0.7)](/filings/0000835011-26-000068.md) | [20.3](/filings/0001628280-25-036842.md) | [21.0](/filings/0000835011-25-000097.md) | [(135) d](/filings/0000835011-26-000031.md) | [(173)](/filings/0000835011-26-000068.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [10.8](/filings/0001628280-24-033884.md) | [4.4](/filings/0001628280-24-044424.md) | [9.8 d](/filings/0000835011-26-000031.md) | [6.3](/filings/0001628280-25-021329.md) | [10.1](/filings/0001628280-25-036842.md) | [7.6](/filings/0000835011-25-000097.md) | [10.1 d](/filings/0000835011-26-000031.md) | [0.7](/filings/0000835011-26-000068.md) | [4.3](/filings/0001628280-25-036842.md) | [4.3](/filings/0000835011-25-000097.md) | [(1.8) d](/filings/0000835011-26-000031.md) | [(39.9)](/filings/0000835011-26-000068.md) |
| Net income | $m | [32.1](/filings/0001628280-24-033884.md) | [13.2](/filings/0001628280-24-044424.md) | [31.1 d](/filings/0000835011-26-000031.md) | [20.6](/filings/0001628280-25-021329.md) | [32.1](/filings/0001628280-25-036842.md) | [23.9](/filings/0000835011-25-000097.md) | [(42.0) d](/filings/0000835011-26-000031.md) | [(3.0)](/filings/0000835011-26-000068.md) | [14.4](/filings/0001628280-25-036842.md) | [15.4](/filings/0000835011-25-000097.md) | [(135) d](/filings/0000835011-26-000031.md) | [(135)](/filings/0000835011-26-000068.md) |
| Diluted EPS | $ per share | [1.44](/filings/0001628280-24-033884.md) | [0.58](/filings/0001628280-24-044424.md) | not reported | [0.92](/filings/0001628280-25-021329.md) | [1.43](/filings/0001628280-25-036842.md) | [1.07](/filings/0000835011-25-000097.md) | not reported | [(0.14)](/filings/0000835011-26-000068.md) | [0.67](/filings/0001628280-25-036842.md) | [0.71](/filings/0000835011-25-000097.md) | not reported | [(6.30)](/filings/0000835011-26-000068.md) |
| Basic EPS | $ per share | [1.44](/filings/0001628280-24-033884.md) | [0.59](/filings/0001628280-24-044424.md) | not reported | [0.92](/filings/0001628280-25-021329.md) | [1.43](/filings/0001628280-25-036842.md) | [1.07](/filings/0000835011-25-000097.md) | not reported | [(0.14)](/filings/0000835011-26-000068.md) | [0.67](/filings/0001628280-25-036842.md) | [0.71](/filings/0000835011-25-000097.md) | not reported | [(6.30)](/filings/0000835011-26-000068.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [22.0](/filings/0001628280-23-027007.md) | [28.0](/filings/0001628280-23-036204.md) | [18.4](/filings/0001628280-25-007962.md) | [19.5](/filings/0001628280-24-019790.md) | [21.0](/filings/0001628280-24-033884.md) | [20.8](/filings/0001628280-24-044424.md) | [25.3](/filings/0000835011-26-000031.md) | [20.1](/filings/0001628280-25-021329.md) | [17.3](/filings/0001628280-25-036842.md) | [13.4](/filings/0000835011-25-000097.md) | [18.5](/filings/0000835011-26-000068.md) | [10.4](/filings/0000835011-26-000068.md) |
| Current assets | $m | [521](/filings/0001628280-23-027007.md) | [504](/filings/0001628280-23-036204.md) | [514](/filings/0001628280-25-007962.md) | [507](/filings/0001628280-24-019790.md) | [546](/filings/0001628280-24-033884.md) | [532](/filings/0001628280-24-044424.md) | [546](/filings/0000835011-26-000031.md) | [517](/filings/0001628280-25-021329.md) | [520](/filings/0001628280-25-036842.md) | [511](/filings/0000835011-25-000097.md) | [523](/filings/0000835011-26-000068.md) | [506](/filings/0000835011-26-000068.md) |
| Total assets | $m | [1,395](/filings/0001628280-23-027007.md) | [1,366](/filings/0001628280-23-036204.md) | [1,392](/filings/0001628280-25-007962.md) | [1,390](/filings/0001628280-24-019790.md) | [1,434](/filings/0001628280-24-033884.md) | [1,441](/filings/0001628280-24-044424.md) | [1,406](/filings/0000835011-26-000031.md) | [1,378](/filings/0001628280-25-021329.md) | [1,386](/filings/0001628280-25-036842.md) | [1,377](/filings/0000835011-25-000097.md) | [1,236](/filings/0000835011-26-000068.md) | [1,031](/filings/0000835011-26-000068.md) |
| Current liabilities | $m | [119](/filings/0001628280-23-027007.md) | [90.1](/filings/0001628280-23-036204.md) | [114](/filings/0001628280-25-007962.md) | [80.3](/filings/0001628280-24-019790.md) | [84.8](/filings/0001628280-24-033884.md) | [82.3](/filings/0001628280-24-044424.md) | [92.5](/filings/0000835011-26-000031.md) | [182](/filings/0001628280-25-021329.md) | [179](/filings/0001628280-25-036842.md) | [184](/filings/0000835011-25-000097.md) | [200](/filings/0000835011-26-000068.md) | [185](/filings/0000835011-26-000068.md) |
| Total liabilities | $m | [588](/filings/0001628280-23-027007.md) | [548](/filings/0001628280-23-036204.md) | [543](/filings/0001628280-25-007962.md) | [525](/filings/0001628280-24-019790.md) | [541](/filings/0001628280-24-033884.md) | [528](/filings/0001628280-24-044424.md) | [573](/filings/0000835011-26-000031.md) | [552](/filings/0001628280-25-021329.md) | [546](/filings/0001628280-25-036842.md) | [523](/filings/0000835011-25-000097.md) | [519](/filings/0000835011-26-000068.md) | [452](/filings/0000835011-26-000068.md) |
| Long-term debt | $m | not reported | not reported | [294](/filings/0001628280-24-006149.md) | not reported | not reported | not reported | [329](/filings/0001628280-25-007962.md) | not reported | not reported | not reported | [260](/filings/0000835011-26-000031.md) | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [808](/filings/0001628280-23-027007.md) | [820](/filings/0001628280-23-036204.md) | [850](/filings/0001628280-25-007962.md) | [867](/filings/0001628280-24-019790.md) | [894](/filings/0001628280-24-033884.md) | [914](/filings/0001628280-24-044424.md) | [834](/filings/0000835011-26-000031.md) | [828](/filings/0001628280-25-021329.md) | [842](/filings/0001628280-25-036842.md) | [855](/filings/0000835011-25-000097.md) | [718](/filings/0000835011-26-000068.md) | [581](/filings/0000835011-26-000068.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [15.1 d](/filings/0001628280-24-033884.md) | [28.4 d](/filings/0001628280-24-044424.md) | [35.2 d](/filings/0000835011-26-000031.md) | [24.6](/filings/0001628280-25-021329.md) | [5.0 d](/filings/0001628280-25-036842.md) | [43.9 d](/filings/0000835011-25-000097.md) | [28.8 d](/filings/0000835011-26-000031.md) | [44.7](/filings/0000835011-26-000068.md) | [11.7 d](/filings/0001628280-25-036842.md) | [36.1 d](/filings/0000835011-25-000097.md) | [29.1 d](/filings/0000835011-26-000031.md) | [7.0](/filings/0000835011-26-000068.md) |
| Capital expenditure | $m | [13.8 d](/filings/0001628280-24-033884.md) | [12.0 d](/filings/0001628280-24-044424.md) | [13.2 d](/filings/0000835011-26-000031.md) | [27.0](/filings/0001628280-25-021329.md) | [6.4 d](/filings/0001628280-25-036842.md) | [19.5 d](/filings/0000835011-25-000097.md) | [18.3 d](/filings/0000835011-26-000031.md) | [19.9](/filings/0000835011-26-000068.md) | [12.2 d](/filings/0001628280-25-036842.md) | [8.5 d](/filings/0000835011-25-000097.md) | [4.8 d](/filings/0000835011-26-000031.md) | [5.7](/filings/0000835011-26-000068.md) |
| Dividends paid | $m | [2.7 d](/filings/0001628280-24-033884.md) | [2.7 d](/filings/0001628280-24-044424.md) | [2.7 d](/filings/0000835011-26-000031.md) | [2.7](/filings/0001628280-25-021329.md) | [2.7 d](/filings/0001628280-25-036842.md) | [2.7 d](/filings/0000835011-25-000097.md) | [2.6 d](/filings/0000835011-26-000031.md) | [2.6](/filings/0000835011-26-000068.md) | [2.6 d](/filings/0001628280-25-036842.md) | [2.6 d](/filings/0000835011-25-000097.md) | [2.6 d](/filings/0000835011-26-000031.md) | [2.6](/filings/0000835011-26-000068.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-033884.md) | [0.0 d](/filings/0001628280-24-044424.md) | [0.0 d](/filings/0000835011-26-000031.md) | [7.0](/filings/0001628280-25-021329.md) | [2.8 d](/filings/0001628280-25-036842.md) | [2.5 d](/filings/0000835011-25-000097.md) | [36.5 d](/filings/0000835011-26-000031.md) | [1.0](/filings/0000835011-26-000068.md) | [0.0 d](/filings/0001628280-25-036842.md) | [0.0 d](/filings/0000835011-25-000097.md) | [0.0 d](/filings/0000835011-26-000031.md) | [0.9](/filings/0000835011-26-000068.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.0](/filings/0001628280-23-027007.md) | [22.2](/filings/0001628280-23-036204.md) | [22.1](/filings/0001628280-24-019790.md) | [22.1](/filings/0001628280-24-033884.md) | [22.4](/filings/0001628280-24-044424.md) | [22.1](/filings/0001628280-25-021329.md) | [22.1](/filings/0001628280-25-036842.md) | [22.1](/filings/0000835011-25-000097.md) | [21.3](/filings/0000835011-26-000068.md) | [21.4](/filings/0001628280-25-036842.md) | [21.4](/filings/0000835011-25-000097.md) | [21.4](/filings/0000835011-26-000068.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 21,371,237 at 2026-04-24, from the cover of the [10-Q filed 2026-04-29](/filings/0000835011-26-000068.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.